686 related articles for article (PubMed ID: 23664668)
1. Toward clinical application of the Keap1-Nrf2 pathway.
Suzuki T; Motohashi H; Yamamoto M
Trends Pharmacol Sci; 2013 Jun; 34(6):340-6. PubMed ID: 23664668
[TBL] [Abstract][Full Text] [Related]
2. The Keap1-Nrf2 cell defense pathway--a promising therapeutic target?
Copple IM
Adv Pharmacol; 2012; 63():43-79. PubMed ID: 22776639
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of the Keap1-Nrf2 system.
Suzuki T; Yamamoto M
Free Radic Biol Med; 2015 Nov; 88(Pt B):93-100. PubMed ID: 26117331
[TBL] [Abstract][Full Text] [Related]
4. Role of the Keap1-Nrf2 pathway in cancer.
Leinonen HM; Kansanen E; Pölönen P; Heinäniemi M; Levonen AL
Adv Cancer Res; 2014; 122():281-320. PubMed ID: 24974185
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution.
Taguchi K; Motohashi H; Yamamoto M
Genes Cells; 2011 Feb; 16(2):123-40. PubMed ID: 21251164
[TBL] [Abstract][Full Text] [Related]
6. The role of Nrf2 in oxidative stress-induced endothelial injuries.
Chen B; Lu Y; Chen Y; Cheng J
J Endocrinol; 2015 Jun; 225(3):R83-99. PubMed ID: 25918130
[TBL] [Abstract][Full Text] [Related]
7. Continuous activation of Nrf2 and its target antioxidant enzymes leads to arsenite-induced malignant transformation of human bronchial epithelial cells.
Yang X; Wang D; Ma Y; Xu X; Zhu Z; Wang X; Deng H; Li C; Chen M; Tong J; Yamanaka K; An Y
Toxicol Appl Pharmacol; 2015 Dec; 289(2):231-9. PubMed ID: 26420645
[TBL] [Abstract][Full Text] [Related]
8. Chemopreventive promise of targeting the Nrf2 pathway.
Yates MS; Kensler TW
Drug News Perspect; 2007 Mar; 20(2):109-17. PubMed ID: 17440634
[TBL] [Abstract][Full Text] [Related]
9. The Keap1-Nrf2 system and diabetes mellitus.
Uruno A; Yagishita Y; Yamamoto M
Arch Biochem Biophys; 2015 Jan; 566():76-84. PubMed ID: 25528168
[TBL] [Abstract][Full Text] [Related]
10. Acetyl-l-carnitine prevents homocysteine-induced suppression of Nrf2/Keap1 mediated antioxidation in human lens epithelial cells.
Yang SP; Yang XZ; Cao GP
Mol Med Rep; 2015 Jul; 12(1):1145-50. PubMed ID: 25776802
[TBL] [Abstract][Full Text] [Related]
11. Hypermethylation of the Keap1 gene inactivates its function, promotes Nrf2 nuclear accumulation, and is involved in arsenite-induced human keratinocyte transformation.
Wang D; Ma Y; Yang X; Xu X; Zhao Y; Zhu Z; Wang X; Deng H; Li C; Gao F; Tong J; Yamanaka K; An Y
Free Radic Biol Med; 2015 Dec; 89():209-19. PubMed ID: 26409248
[TBL] [Abstract][Full Text] [Related]
12. The keap1-nrf2 cellular defense pathway: mechanisms of regulation and role in protection against drug-induced toxicity.
Copple IM; Goldring CE; Kitteringham NR; Park BK
Handb Exp Pharmacol; 2010; (196):233-66. PubMed ID: 20020265
[TBL] [Abstract][Full Text] [Related]
13. The Keap1-Nrf2 system as an in vivo sensor for electrophiles.
Uruno A; Motohashi H
Nitric Oxide; 2011 Aug; 25(2):153-60. PubMed ID: 21385624
[TBL] [Abstract][Full Text] [Related]
14. Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosis.
Stępkowski TM; Kruszewski MK
Free Radic Biol Med; 2011 May; 50(9):1186-95. PubMed ID: 21295136
[TBL] [Abstract][Full Text] [Related]
15. Alterations in the Nrf2-Keap1 signaling pathway and its downstream target genes in rat brain under stress.
Djordjevic J; Djordjevic A; Adzic M; Mitic M; Lukic I; Radojcic MB
Brain Res; 2015 Mar; 1602():20-31. PubMed ID: 25598205
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N
Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol protects human keratinocytes HaCaT cells from UVA-induced oxidative stress damage by downregulating Keap1 expression.
Liu Y; Chan F; Sun H; Yan J; Fan D; Zhao D; An J; Zhou D
Eur J Pharmacol; 2011 Jan; 650(1):130-7. PubMed ID: 20951123
[TBL] [Abstract][Full Text] [Related]
18. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer.
Singh A; Misra V; Thimmulappa RK; Lee H; Ames S; Hoque MO; Herman JG; Baylin SB; Sidransky D; Gabrielson E; Brock MV; Biswal S
PLoS Med; 2006 Oct; 3(10):e420. PubMed ID: 17020408
[TBL] [Abstract][Full Text] [Related]
19. Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth.
Ohta T; Iijima K; Miyamoto M; Nakahara I; Tanaka H; Ohtsuji M; Suzuki T; Kobayashi A; Yokota J; Sakiyama T; Shibata T; Yamamoto M; Hirohashi S
Cancer Res; 2008 Mar; 68(5):1303-9. PubMed ID: 18316592
[TBL] [Abstract][Full Text] [Related]
20. Contradictory roles of Nrf2/Keap1 signaling pathway in cancer prevention/promotion and chemoresistance.
Jeddi F; Soozangar N; Sadeghi MR; Somi MH; Samadi N
DNA Repair (Amst); 2017 Jun; 54():13-21. PubMed ID: 28415030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
